About NeuraSignal
NeuraSignal is a Healthcare company based in Los Angeles (United States) founded in 2013. Provider of robotic and AI-driven transcranial Doppler ultrasound technology for real-time blood flow data capture. Its chief executive, as recorded, is Diane Bryant. Its Indian entity Novasignal India Private Limited reported revenue of ₹5.30 Cr. NeuraSignal offers products and services including NG2 Intelligent Ultrasound, NG2 Classic Ultrasound, NG View, and NeuraCare. Its focus areas include Life Sciences, Imaging Diagnostics, Ultrasound and HealthTech. Its competitors include Butterfly Network, Exo and SonoSite; 2 of its 3 listed competitors have raised funding.
Company details
NeuraSignal was founded in 2013 in Los Angeles, United States, and operates in the medical technology sector. Robotic and AI-driven transcranial Doppler ultrasound systems are developed to enable real-time capture of cerebral blood flow data. The NovaGuide Platform is utilized, incorporating advanced algorithms to assist clinicians in diagnosis and patient management within neurovascular applications. Operations focus on hardware and software integration for healthcare settings.
- Headquarters Los Angeles, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website neurasignal.com
- Social LinkedIn X Facebook
- Legal Name Neurasignal, Inc.
- Date of Incorporation 09 Sep, 2020
- Indian entity revenue₹5.30 Cr
FY 2022 · +516% YoY
- Indian entity net profit₹49.6 Lakh
FY 2022 · 9% margin
- Indian entity EBITDA₹71.4 Lakh
FY 2022 · 13% margin
- Latest Funding Round$213.21K (USD), Grant
Sep 2018
- Investors
Associated legal entities of NeuraSignal
NeuraSignal operates through Novasignal India Private Limited (under liquidation). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Novasignal India Private Limited CIN U74999KA2020FTC138377 | Under Liquidation | 09 Sep 2020 | Bangalore, Karnataka | ₹5.3 Cr | 3 | View details |
Products & Services of NeuraSignal
NeuraSignal offers a comprehensive portfolio of products and services, including NG2 Intelligent Ultrasound, NG2 Classic Ultrasound, NG View, and NeuraCare.
Provides real-time cerebral hemodynamics monitoring using AI and robotics.
Offers standard ultrasound for brain blood flow assessment.
Enables viewing of ultrasound data for diagnostic purposes.
Facilitates patient care through integrated ultrasound applications.
Funding Insights of NeuraSignal
- Total Rounds 4
- Last Round Grant — $213,206
- First Round $149,294
(Jan 2015)
- Investors Count 1
All 4 funding rounds of NeuraSignal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in NeuraSignal
NeuraSignal has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for NeuraSignal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Novasignal India Private Limited (NeuraSignal)
Novasignal India Private Limited is the primary company behind NeuraSignal. The board of Novasignal India Private Limited currently have 3 directors; the longest-serving is Sivasankaran Krishnan, appointed in 2020. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sivasankaran Krishnan DIN 03312226 | Director | 09 Sep 2020 | 6 yrs 1 mo | Novasignal India Private Limited |
| Vani Vijayaraj DIN 10311160 | Director | 07 Sep 2023 | 3 yrs 1 mo | Novasignal India Private Limited |
| Girish Krishna Hingorani DIN 10013106 | IRP/RP/Liquidator | 06 May 2024 | 2 yrs 5 mo | Novasignal India Private Limited |
People of NeuraSignal
1 people are tracked at NeuraSignal (1 in leadership).
| Name | Role | Group |
|---|---|---|
Diane Bryant | CEO | Leadership |
Complete people profiles for NeuraSignal
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of NeuraSignal
Figures of Novasignal India Private Limited, the primary company behind NeuraSignal, for FY 2022. Revenue was ₹5.30 Cr (+516% year on year). Net profit was ₹49.6 Lakh (9% margin). EBITDA was ₹71.4 Lakh (13% margin).
- ₹5.30 CrRevenue · FY 2022 · +516% YoY
- ₹49.6 LakhNet profit · 9% margin
- ₹71.4 LakhEBITDA · 13% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Novasignal India Private Limited are on its company page.
Detailed financial statements for NeuraSignal
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of NeuraSignal
3 dated milestones of NeuraSignal across 5 years, from founding to its latest funding, stage changes and deals.
- Founded NeuraSignal is founded.
- Funding First funding round of $149K.
- Funding Latest funding round, Grant, of $213K.
Competitors of NeuraSignal
NeuraSignal has 3 listed competitors in our database, 2 of them funded. They include Butterfly Network, Exo and SonoSite.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| butterflynetwork.com | 2011 | Guilford, United States | $350M | 225 | Handheld ultrasound devices are developed for whole-body medical imaging. | |
| exo.inc | 2015 | Redwood, United States | $463.39M | 152 | Ultrasound images are analyzed via AI-based software provided by Exo. | |
| sonosite.com | 1986 | Bothell, United States | 606 | Hand-carried ultrasound systems for medical specialties are developed and distributed. |
Detailed competitors of NeuraSignal
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NeuraSignal
The website of NeuraSignal (neurasignal.com) receives about 6.9K visits a month.
- Monthly visits6.9K
▲ 125.8% vs previous month
Top companies in Imaging Diagnostics
3 companies that operate in the same segment as NeuraSignal (Imaging Diagnostics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neurasignal
Complete news archive for NeuraSignal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuraSignal
NeuraSignal was founded in 2013 and raised its 1st funding round 2 years after it was founded.
NeuraSignal is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Diane Bryant is the CEO of NeuraSignal, as recorded in our data.
The primary company behind NeuraSignal, Novasignal India Private Limited, reported revenue of ₹5.30 Cr for FY 2022, up 516% year on year.
NeuraSignal was founded in 2013 in Los Angeles, United States, and operates in the medical technology sector. Robotic and AI-driven transcranial Doppler ultrasound systems are developed to enable real-time capture of cerebral blood flow data. The NovaGuide Platform is utilized, incorporating advanced algorithms to assist clinicians in diagnosis and patient management within neurovascular applications. Operations focus on hardware and software integration for healthcare settings.
NeuraSignal's top competitors include Butterfly Network, Exo and SonoSite.
NeuraSignal offers NG2 Intelligent Ultrasound, NG2 Classic Ultrasound, NG View, and NeuraCare.
NeuraSignal has 1 investor. Key investors include HHS.
NeuraSignal operates through Novasignal India Private Limited.
The legal entities of NeuraSignal currently have 3 directors, including Vani Vijayaraj, Sivasankaran Krishnan, Girish Krishna Hingorani.